David L Hava
7PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 08, 2024
Rational Engineering of Escherichia coli Nissle 1917 as Live Biotherapeutic to Degrade Uremic Toxin Precursors.David Lubkowicz, David L Hava, Kim Lewis
|Aug 09, 2023
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells.Liliana M Sanmarco, Joseph M Rone, Carolina M Polonio
|May 25, 2023
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.Jason J Luke, Sarina A Piha-Paul, Theresa Medina
|Feb 02, 2023
Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster.Aida Kalantari, Michael J James, Lauren A Renaud
|Mar 07, 2022
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria.David Lubkowicz, Nicholas G Horvath, Michael J James
|Nov 08, 2019
A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics.David L Hava, Lisa Tan, Patrick Johnson
Pageof 2
Frequent Collaborators
2 joint publications
Anna Sokolovska
2 joint publications
David Lubkowicz
1 joint publications
Joseph M Rone
1 joint publications
Carolina M Polonio
1 joint publications
Cristina Gutierrez-Vazquez
1 joint publications
Agustin Plasencia
1 joint publications
Zhaorong Li
1 joint publications
Hong-Gyun Lee
1 joint publications
Chun-Cheih Chao
1 joint publications
Claudia M Rejano-Gordillo
